With the expected release of the remaining JFK assassination files following President Donald Trump's executive order, here is a look back on the documents' original declassification timeline.

CHICAGO (Reuters) - Robert F. Kennedy Jr., President Donald Trump's pick to lead the top U.S. health agency, told U.S. senators during his confirmation hearing on Wednesday that he would finalize regulations aimed at increasing the participation of diverse patient populations in clinical trials.

President Trump signed an executive order Thursday directing the release of federal government documents related to the assassinations of former President John F. Kennedy, former Attorney General

Robert F. Kennedy Jr., President Trump’s nominee for Health and Human Services (HHS) secretary, sat through his second Senate confirmation hearing in as many days on Thursday, with his chances of

Robert F. Kennedy Jr.’s nomination for health and human services secretary has stalled as Senate Democrats and Republicans take issue with his views.

Robert F. Kennedy Jr. focused a lot of his proposals on diet-related diseases among low-income Americans during his confirmation hearing on Wednesday.

The longtime liberal faces deep skepticism over his public health views. “Frankly, you frighten people,” one Democratic senator told his former roommate.

While Mr. Kennedy, seeking the job of health secretary, has been vocal about vaccines and his desire to overhaul the nation’s diet, he has said very little about other issues.

The Senate Finance Committee holds Health and Human Services secretary nominee Robert F. Kennedy Jr.'s first confirmation hearing today. Follow here for live updates.

If he is confirmed as health and human services secretary, Kennedy would oversee the implementation of Medicaid, in addition to Medicare and the Affordable Care Act.

Robert F. Kennedy Jr’s confirmation hearings began Wednesday before the Senate Finance Committee. He appears before the Health, Education, Labor and Pension committee on Thursday.

Cigna To Reform Prior Authorization, Provider Services In 2025 The Cigna Group will spend up to $150 million to reform its prior authorization, patient advocacy and provider services this year, CEO David Cordani said Thursday.